PGS Sample Set (PSS): PSS000008

Sample #1

Phenotype Coronary heart disease represented a composite of fatal or non-fatal myocardial infarction, coronary artery bypass grafting, or percutaneous coronary intervention
Sample Ancestry European

Sample Numbers

Total number
6,978 individuals
Detailed numbers
149 cases (2.14%)
6,829 controls
79.7% Male samples
Number of Cohort(s) 1
Sample distribution
ControlsCases
Sample gender distribution
% Female% Male

Cohort(s)

Loading, please wait
Cohort Short Name
Cohort Full Name
Previous/other/additional names (e.g. sub-cohorts)
ASCOTAnglo-Scandinavian Cardiac Outcomes Trial
Showing 1 to 1 of 1 rows

Additional information

Primary prevention cohorts

Sample #2

Phenotype Coronary heart disease represented a composite of fatal or non-fatal myocardial infarction, coronary artery bypass grafting, or percutaneous coronary intervention
Sample Ancestry European (Swedish)

Sample Numbers

Total number
27,271 individuals
Detailed numbers
38.7% Male samples
Number of Cohort(s) 1
Sample gender distribution
% Female% Male

Cohort(s)

Loading, please wait
Cohort Short Name
Cohort Full Name
Previous/other/additional names (e.g. sub-cohorts)
MDCMalmö Diet and Cancer Study
Showing 1 to 1 of 1 rows

Additional information

Primary prevention cohorts

Sample #3

Phenotype Coronary heart disease represented a composite of fatal or non-fatal myocardial infarction, coronary artery bypass grafting, or percutaneous coronary intervention
Sample Ancestry European

Sample Numbers

Total number
8,749 individuals
Detailed numbers
108 cases (1.23%)
8,641 controls
67.8% Male samples
Number of Cohort(s) 1
Sample distribution
ControlsCases
Sample gender distribution
% Female% Male

Cohort(s)

Loading, please wait
Cohort Short Name
Cohort Full Name
Previous/other/additional names (e.g. sub-cohorts)
JUPITERJustification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin
Showing 1 to 1 of 1 rows

Additional information

Primary prevention cohorts